A mouse subcutaneous breast tumor model was established for further evaluating the invivo efficacy of HER2-scFv-armed macrophage membrane camouflaged GEM@PLGA@HM and other PLGA NPs (Fig. 7A). The gene discussed is ERBB2; the disease is breast neoplasm.